Literature DB >> 26392109

The role of Kaposi's sarcoma-associated herpesvirus infection in the proliferation of human bladder cancer cells.

Jisu Lee1, Hyungtaek Jeon1, Seung-Min Yoo1, Jinsung Park2, Myung-Shin Lee3.   

Abstract

Existing evidence suggests a possible role of viruses in human bladder cancer development. Recently, Kaposi's sarcoma-associated herpesvirus (KSHV) was reported to be the most frequently detected virus in bladder cancer tissue from Croatian patients on screening with the Lawrence Livermore Microbial Detection Array. In the current study, to investigate the functional roles of KSHV in bladder cancer, five bladder cancer cell lines were infected with KSHV and their tumour progression-associated changes investigated. Four KSHV-infected bladder cancer cell lines were established; two invasive bladder cancer cell lines showed higher proliferation rates than uninfected cells. Additionally, these KSHV-infected invasive bladder cancer cells showed a greater number of colonies, which were also significantly larger than those of uninfected cells, in a soft agar colony formation assay. cDNA microarray analysis showed that various genes associated with cell proliferation and cancer development were upregulated in these KSHV-infected bladder cancer cells. Taken together, we suggest that KSHV infection affects the proliferation of a subset of invasive bladder cancer cells and may therefore play a role in their oncogenic progression. Further studies are required to elucidate the exact mechanism used by KSHV to promote bladder cancer progression.

Entities:  

Keywords:  Bladder cancer; Human herpesvirus 8; Kaposi’s sarcoma-associated herpesvirus; Microarray; Proliferation

Mesh:

Year:  2015        PMID: 26392109     DOI: 10.1007/s13277-015-4096-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  38 in total

1.  Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes.

Authors:  Marta Sanchez-Carbayo; Nicholas D Socci; Elizabeth Charytonowicz; Minglan Lu; Michael Prystowsky; Geoffrey Childs; Carlos Cordon-Cardo
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

2.  Association of Kaposi’s sarcoma-associated herpesvirus (KSHV) with bladder cancer in Croatian patients.

Authors:  Martina Paradžik; Viljemka Bučević-Popović; Marijan Šitum; Crystal J Jaing; Marina Degoricija; Kevin S McLoughlin; Said I Ismail; Volga Punda-Polić; Janoš Terzić
Journal:  Tumour Biol       Date:  2014-01

3.  Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer.

Authors:  I D Markl; P A Jones
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

4.  Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone.

Authors:  Kevin F Brulois; Heesoon Chang; Amy Si-Ying Lee; Armin Ensser; Lai-Yee Wong; Zsolt Toth; Sun Hwa Lee; Hye-Ra Lee; Jinjong Myoung; Don Ganem; Tae-Kwang Oh; Jihyun F Kim; Shou-Jiang Gao; Jae U Jung
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

5.  Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.

Authors:  Carlos Bais; Albert Van Geelen; Pilar Eroles; Agata Mutlu; Chiara Chiozzini; Sergio Dias; Roy L Silverstein; Shahin Rafii; Enrique A Mesri
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

6.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

7.  The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.

Authors:  Akrit Sodhi; Risa Chaisuparat; Jiadi Hu; Amanda K Ramsdell; Brendan D Manning; Edward A Sausville; Earl T Sawai; Alfredo Molinolo; J Silvio Gutkind; Silvia Montaner
Journal:  Cancer Cell       Date:  2006-08       Impact factor: 31.743

8.  Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients.

Authors:  Hala Badawi; Hanem Ahmed; Ahmed Ismail; Manal Diab; Magd Moubarak; Afkar Badawy; Mohamed Saber
Journal:  Medscape J Med       Date:  2008-10-08

9.  Etiological correlation of human papillomavirus infection in the development of female bladder tumor.

Authors:  Kazuyoshi Shigehara; Shohei Kawaguchi; Toshiyuki Sasagawa; Kazufumi Nakashima; Takao Nakashima; Masayoshi Shimamura; Mikio Namiki
Journal:  APMIS       Date:  2013-04-23       Impact factor: 3.205

10.  Correlation between human papillomavirus infection and bladder transitional cell carcinoma.

Authors:  M R Barghi; A Hajimohammadmehdiarbab; S M M Hosseini Moghaddam; B Kazemi
Journal:  BMC Infect Dis       Date:  2005-11-08       Impact factor: 3.090

View more
  2 in total

1.  Latent Kaposi's sarcoma-associated herpesvirus infection in bladder cancer cells promotes drug resistance by reducing reactive oxygen species.

Authors:  Suhyuk Lee; Jaehyuk Jang; Hyungtaek Jeon; Jisu Lee; Seung-Min Yoo; Jinsung Park; Myung-Shin Lee
Journal:  J Microbiol       Date:  2016-10-29       Impact factor: 3.422

2.  RNA-Seq of Kaposi's sarcoma reveals alterations in glucose and lipid metabolism.

Authors:  For Yue Tso; Andrew V Kossenkov; Salum J Lidenge; Owen Ngalamika; John R Ngowi; Julius Mwaiselage; Jayamanna Wickramasinghe; Eun Hee Kwon; John T West; Paul M Lieberman; Charles Wood
Journal:  PLoS Pathog       Date:  2018-01-19       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.